Literature DB >> 26016457

Rg1 exhibits neuroprotective effects by inhibiting the endoplasmic reticulum stress-mediated c-Jun N-terminal protein kinase apoptotic pathway in a rat model of Alzheimer's disease.

Jun-Shan Mu1, Hang Lin1, Jian-Xin Ye1, Min Lin1, Xiao-Ping Cui1.   

Abstract

The neuroprotective agents currently used to treat Alzheimer's disease (AD) often only target one aspect of the disease process. Therefore, identifying effective drug targets associated with the pathogenesis of AD is critical for the production of novel AD therapeutic strategies. The present study aimed to investigate the underlying mechanisms of the neuroprotective effects of Rg1 on a rat model of AD. A double transgenic β‑amyloid (Aβ) precursor protein/PS1 rat model was established, which co‑expressed mutations associated with AD. Aβ plaques and neurofibrillary tangles (NFTs) were detected by immunohistochemistry. The detection of the protein expression levels of caspase‑3 and terminal deoxynucleotidyl‑transferase‑mediated dUTP nick end labeling (TUNEL) staining were used to determine the level of apoptosis in the brain tissue. The expression levels of the endoplasmic reticulum (ER) stress biomarker, glucose‑regulated protein 78 (Grp78), and the mitochondrial apoptosis biomarkers, B‑cell lymphoma 2 (Bcl‑2) and Bcl‑2‑associated X protein (Bax), were analyzed by western blotting. Furthermore, the expression of the proteins associated with the ER stress unfolded protein response (UPR) was determined, in order to examine the levels of ER stress. The mRNA expression of downstream genes of UPR were also detected by reverse transcription‑polymerase chain reaction. The protein expression levels of the apoptosis‑associated phosphorylated‑c‑Jun N‑terminal protein kinase (p‑JNK), caspase‑12 and cAMP response element‑binding transcription factor homologous protein were determined by western blotting. The results of the present study indicated that the accumulation of NFTs and Aβ plaques was significantly decreased in the Rg1‑treated AD rats, compared with untreated AD rats. The expression of caspase‑3 and the number of TUNEL‑positive cells were also significantly decreased in the Rg1‑treated rats, as compared with the AD rats. Furthermore, treatment with Rg1 significantly reduced the expression of Grp78, and triggered inositol‑requiring enzyme‑1 (IRE‑1) and phosphorylated protein kinase RNA‑like ER kinase‑associated ER stress. The IRE‑1 UPR pathway downstream gene, tumor necrosis factor receptor‑associated factor 2, was significantly decreased in rats treated with Rg1, compared with untreated AD rats. Furthermore, the activation of p‑JNK was also inhibited when AD rats were treated with Rg1. In conclusion, Rg1 was shown to function as an important factor that inhibits the accumulation of NFTs and Aβ via inhibition of the ER stress‑mediated pathway. Blocking of this pathway was triggered by the IRE‑1 and TRAF2 pathway, as a result of inhibition of the expression of p‑JNK.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26016457     DOI: 10.3892/mmr.2015.3853

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

1.  The Rho kinase inhibitor fasudil attenuates Aβ1-42-induced apoptosis via the ASK1/JNK signal pathway in primary cultures of hippocampal neurons.

Authors:  Ye Gao; Yuqing Yan; Qingli Fang; Nianping Zhang; Gajendra Kumar; Jihong Zhang; Li-Juan Song; Jiezhong Yu; Linhu Zhao; Han-Ting Zhang; Cun-Gen Ma
Journal:  Metab Brain Dis       Date:  2019-09-03       Impact factor: 3.584

2.  Bis(ethylmaltolato)oxidovanadium (IV) alleviates neuronal apoptosis through regulating peroxisome proliferator-activated receptor γ in a triple transgenic animal model of Alzheimer's disease.

Authors:  Zhijun He; Jianxi Song; Xuexia Li; Xiaoqian Li; Huazhang Zhu; Chong Wu; Wen Xiao; Xiubo Du; Jiazuan Ni; Nan Li; Qiong Liu
Journal:  J Biol Inorg Chem       Date:  2021-07-08       Impact factor: 3.358

3.  Ginsenoside Rg1 Regulates SIRT1 to Ameliorate Sepsis-Induced Lung Inflammation and Injury via Inhibiting Endoplasmic Reticulum Stress and Inflammation.

Authors:  Qian-Lu Wang; Lei Yang; Yue Peng; Min Gao; Ming-Shi Yang; Wei Xing; Xian-Zhong Xiao
Journal:  Mediators Inflamm       Date:  2019-02-24       Impact factor: 4.711

4.  YiQiFuMai Powder Injection Ameliorates Cerebral Ischemia by Inhibiting Endoplasmic Reticulum Stress-Mediated Neuronal Apoptosis.

Authors:  Guosheng Cao; Huana Zhou; Nan Jiang; Yuwei Han; Yang Hu; Yuanyuan Zhang; Jin Qi; Junping Kou; Boyang Yu
Journal:  Oxid Med Cell Longev       Date:  2016-03-20       Impact factor: 6.543

Review 5.  Ginsenosides: A Potential Neuroprotective Agent.

Authors:  Mengmeng Zheng; Yizhou Xin; Yujuan Li; Fangxue Xu; Xiaozhi Xi; Hong Guo; Xiaowei Cui; Hui Cao; Xi Zhang; Chunchao Han
Journal:  Biomed Res Int       Date:  2018-05-08       Impact factor: 3.411

6.  Ginsenoside Rg1 reduces β‑amyloid levels by inhibiting CDΚ5‑induced PPARγ phosphorylation in a neuron model of Alzheimer's disease.

Authors:  Qiankun Quan; Xi Li; Jianjun Feng; Jixing Hou; Ming Li; Bingwei Zhang
Journal:  Mol Med Rep       Date:  2020-08-07       Impact factor: 2.952

7.  Ginsenoside Rg1 Prevents Doxorubicin-Induced Cardiotoxicity through the Inhibition of Autophagy and Endoplasmic Reticulum Stress in Mice.

Authors:  Zhi-Meng Xu; Cheng-Bin Li; Qing-Ling Liu; Ping Li; Hua Yang
Journal:  Int J Mol Sci       Date:  2018-11-20       Impact factor: 5.923

Review 8.  Panax ginseng components and the pathogenesis of Alzheimer's disease (Review).

Authors:  Mayya Petrovna Razgonova; Valery Vyacheslavovich Veselov; Alexander Mikhailovich Zakharenko; Kirill Sergeyevich Golokhvast; Alexander Evgenyevich Nosyrev; Giancarlo Cravotto; Aristidis Tsatsakis; Demetrios A Spandidos
Journal:  Mol Med Rep       Date:  2019-02-19       Impact factor: 2.952

Review 9.  ER stress and UPR in Alzheimer's disease: mechanisms, pathogenesis, treatments.

Authors:  Amir Ajoolabady; Dan Lindholm; Jun Ren; Domenico Pratico
Journal:  Cell Death Dis       Date:  2022-08-15       Impact factor: 9.685

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.